MedTrace Logo

Blood-brain Barrier Permeability in Alzheimer's Disease

NCT01574456 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39

Last updated 2013-12-10

No results posted yet for this study

Summary

The main aim of the present study is to improve our understanding of the role of blood-brain barrier function in dementia of the Alzheimer's type. The investigators hypothesize that microvascular dysfunction - more specifically "cerebral perfusion and blood-brain barrier leakage" - is a determinant of cognitive decline and cortical atrophy in Alzheimer's disease.

Conditions

Sponsors & Collaborators

  • Maastricht University Medical Center

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01574456 on ClinicalTrials.gov